About PIQUR
PIQUR is a company based in Basel (Switzerland) founded in 2011. PIQUR has raised $54.12 million across 4 funding rounds from investors including Versant Ventures and Eurostars. The company has 1 employees as of July 01, 2024. PIQUR operates in a competitive market with competitors including Daré Bioscience, Atossa Therapeutics, Olema Oncology, Minerva Biotechnologies and Puma Biotechnology, among others.
- Headquarter Basel, Switzerland
- Employees 1 as on 01 Jul, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$54.12 M (USD)
in 4 rounds
-
Latest Funding Round
$18.98 M (USD), Series A
Jul 16, 2015
-
Investors
Versant Ventures
& 1 more
-
Employee Count
1
as on Jul 01, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of PIQUR
PIQUR has successfully raised a total of $54.12M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $18.98 million completed in July 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in PIQUR
PIQUR has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Versant Ventures and Eurostars.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for PIQUR
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PIQUR
Investment portfolio details for PIQUR
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PIQUR
Detailed financials for PIQUR
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Piqur Comparisons
Peer comparison for PIQUR
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PIQUR
PIQUR operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Daré Bioscience, Atossa Therapeutics, Olema Oncology, Minerva Biotechnologies and Puma Biotechnology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-hormonal pharmaceutical products for female contraceptives are developed.
|
|
| Locked | Locked | Locked |
Drugs for breast cancer treatment and prevention are developed.
|
|
| Locked | Locked | Locked |
Drug therapeutics for breast cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Cell therapy and antibodies are developed to treat cancer.
|
|
| Locked | Locked | Locked |
Tyrosine kinase inhibitors for breast cancer are developed.
|
Detailed competitors of PIQUR
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Piqur
Complete news archive for PIQUR
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PIQUR
PIQUR was founded in 2011 and raised its 1st funding round 2 years after it was founded.
PIQUR is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.
PIQUR is a funded company, having raised a total of $54.12M across 4 funding rounds to date.
As of Jul 01, 2024, the latest employee count at PIQUR is 1.
PIQUR was founded in 2011 in Basel, Switzerland, within the biotechnology sector. Focus is placed on the discovery and development of anti-cancer therapeutics that inhibit lipid kinase (PI3K) and mTOR pathways. The lead candidate, PQR309, a small-molecule pan-PI3KmTOR inhibitor, is advanced in phase 2 clinical trials for lymphomas and solid tumors. Operations center on oncology drug innovation for potential therapeutic applications.
PIQUR's top competitors include Atossa Therapeutics, Daré Bioscience and Puma Biotechnology.
PIQUR has 2 investors. Key investors include Versant Ventures, and Eurostars.